Low-generation asymmetric dendrimers exhibit minimal toxicity and effectively complex DNA

Journal of Peptide Science

Volumn 17, Issue 6, 2011, Pages 470-478

  Shah, Neha ^a   Steptoe, Raymond J ^a   Parekh, Harendra S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Asymmetric dendrimers; Cytotoxicity; Low generation peptides; PAMAM G1; Toroids

Indexed keywords

ARGININE; DENDRIMER; DNA; POLYAMIDOAMINE;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DNA TRANSFECTION; DRUG DELIVERY SYSTEM; GENE TARGETING; GENE VECTOR; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TOXICITY TESTING;

CELL SURVIVAL; DENDRIMERS; DNA, CIRCULAR; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEK293 CELLS; HUMANS; KINETICS; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR CONFORMATION; PLASMIDS;

EID: 79955919831     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1347     Document Type: Article

References (53)

1. Haensler J, Szoka Jr FC. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate Chem. 1993; 4: 372-379.
2. Lungwitz U, Breunig M, Blunk T, Gopferich A. Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 2005; 60: 247-266.
3. Ohsaki M, Okuda T, Wada A, Hirayama T, Niidome T, Aoyagi H. In vitro gene transfection using dendritic poly(L-lysine). Bioconjugate Chem. 2002; 13: 510-517.
4. Luo K, Li C, Wang G, Nie Y, He B, Wu Y, Gu Z. Peptide dendrimers as efficient and biocompatible gene delivery vectors: Synthesis and in vitro characterization. J. Controlled Release 2010; DOI:10.1016/j.physletb.2003.10.071.
5. Dufes C, Uchegbu IF, Schatzlein AG. Dendrimers in gene delivery. Adv. Drug Delivery Rev. 2005; 57: 2177-2202.
6. Balogh LP, Nigavekar SS, Sung LY, Balogh P, Shi XY, Cook AT, Minc LD, Khan MK. Development of radioactive gold-dendrimer nanocomposite devices to treat tumor microvasculature: Synthesis and biodistribution. J. Nucl. Med. 2003; 44: 1094.
7. Boas U, Heegaard PMH. Dendrimers in drug research. Chem. Soc. Rev. 2004; 33: 43-63.
8. Herborn CU, Barkhausen J, Paetsch I, Hunold P, Mahler M, Shamsi K, Nagel E. Coronary arteries: Contrast-enhanced MR imaging with SH L 643A-Experience in 12 volunteers. Radiology 2003; 229: 217-223.
9. Tomalia DA. Starburst(R) dendrimers-Nanoscopic supermolecules according dendritic rules and principles. Macromol. Symp. 1996; 101: 243-255.
10. Hawker CJ, Frechet JMJ. Preparation of polymers with controlled molecular architecture-A new convergent approach to dendritic macromolecules. J. Am. Chem. Soc. 1990; 112: 7638-7647.
11. Eichman JD, Bielinska AU, Kukowska-Latallo JF, Baker JR Jr. The use of PAMAM dendrimers in the efficient transfer of genetic material into cells. Pharm. Sci. Technol. 2000; 3: 232-245.
12. Roberts JC, Bhalgat MK, Zera RT. Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst(TM) dendrimers. J. Biomed. Mater. Res. 1996; 30: 53-65.
13. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R. Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of I-125-labelled polyamidoamine dendrimers in vivo. J. Controlled Release 2000; 65: 133-148.
14. KukowskaLatallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 4897-4902.
15. Braun CS, Vetro JA, Tomalia DA, Koe GS, Koe JG, Middaugh CR. Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J. Pharm. Sci. 2005; 94: 423-436.
16. Svenson S, Tomalia DA. Dendrimers in biomedical applications-Reflections on the field. Adv. Drug Delivery Rev. 2005; 57: 2106-2129.
17. Krishna TR, Jain S, Tatu US, Jayaraman N. Synthesis and biological evaluation of 3-amino-propan-1-ol based poly(ether imine) dendrimers. Tetrahedron 2005; 61: 4281-4288.
18. Boyd BJ. Past and future evolution in colloidal drug delivery systems. Expert Opinion on Drug Delivery 2008; 5: 69-85.
19. Merritt AT. Solution phase combinatorial chemistry. Comb. Chem. High Throughput Screening 1998; 1: 57-72.
20. Merrifield RB. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 1963; 85: 2149-2154.
21. Chan WC, White PD. Basic principles. In Fmoc solid phase peptide synthesis A practical approach. Oxford University Press: New York, 2000; 9-40.
22. Atherton E, Sheppard RC. Solid phase synthesis-The Merrifield technique and Fluorenylmethoxycarbonyl (Fmoc) amino acids. In Solid phase peptide synthesis A practical approach. IRL Press at Oxford University Press: Oxford, England; New York, 1989; 13-37 and 47-61.
23. Sheppard R. The fluorenymethoxycarbonyl group in solid phase synthesis. J. Pept. Sci. 2003; 9: 545-552.
24. Kumar P, Ban HS, Kim SS, Wu HQ, Pearson T, Greiner DL, Laouar A, Yao JH, Haridas V, Habiro K, Yang YG, Jeong JH, Lee KY, Kim YH, Kim SW, Peipp M, Fey GH, Manjunath N, Shultz LD, Lee SK, Shankar P. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 2008; 134: 577-586.
25. Roberts JC, Adams YE, Tomalia D, Mercer-Smith JA, Lavallee DK. Using starburst dendrimers as linker molecules to radiolabel antibodies. Bioconjugate Chem. 1990; 1: 305-8.
26. Fajac I, Briand P, Monsigny M. Gene therapy of cystic fibrosis: The glycofection approach. Glycoconjugate J. 2001; 18: 723-729.
27. Parekh HS. The advance of dendrimers-A versatile targeting platform for gene/drug delivery. Curr. Pharm. Des. 2007; 13: 2837-2850.
28. Mutalik S, Hewavitharana AK, Shaw PN, Anissimov YG, Roberts MS, Parekh HS. Development and validation of a reversed-phase high-performance liquid chromatographic method for quantification of peptide dendrimers in human skin permeation experiments. J. Chromatogr. B 2009; 877: 3556-3562.
29. Parekh HS, Marano RJ, Rakoczy EP, Blanchfield J, Toth I. Synthesis of a library of polycationic lipid core dendrimers and their evaluation in the delivery of an oligonucleotide with hVEGF inhibition. Bioorg. Med. Chem. 2006; 14: 4775-4780.
30. URL: [last accessed November 2010].
31. Sarin VK, Kent SBH, Tam JP, Merrifield RB. Quantitative monitoring of solid-phase peptide-synthesis by the ninhydrin reaction. Anal. Biochem. 1981; 117: 147-157.
32. Wiethoff CM, Gill ML, Koe GS, Koe JG, Middaugh CR. A fluorescence study of the structure and accessibility of plasmid DNA condensed with cationic gene delivery vehicles. J. Pharm. Sci. 2003; 92: 1272-1285.
33. Bottcher C, Endisch C, Fuhrhop JH, Catterall C, Eaton M. High-yield preparation of oligomeric C-type DNA toroids and their characterization by cryoelectron microscopy. J. Am. Chem. Soc. 1998; 120: 12-17.
34. Bloomfield VA. Condensation of DNA by multivalent cations-considerations on mechanism. Biopolymers 1991; 31: 1471-1481.
35. Arscott PG, Ma CL, Wenner JR, Bloomfield VA. DNA condensation by cobalt hexaammine(III) in alcohol-water mixtures-dielectric-constant and other solvent effects. Biopolymers 1995; 36: 345-364.
36. Slita AV, Kasyanenko NA, Nazarova OV, Gavrilova II, Eropkina EM, Sirotkin AK, Smirnova TD, Kiselev OI, Panarin EF. DNA-polycation complexes-Effect of polycation structure on physico-chemical and biological properties. J. Biotechnol. 2007; 127: 679-693.
37. Dunlap DD, Maggi A, Soria MR, Monaco L. Nanoscopic structure of DNA condensed for gene delivery. Nucleic Acids Res. 1997; 25: 3095-3101.
38. Golan R, Pietrasanta LI, Hsieh W, Hansma HG. DNA Toroids: Stages in Condensation. Biochemistry 1999; 38: 14 069-14 076.
39. Martin AL, Davies MC, Rackstraw BJ, Roberts CJ, Stolnik S, Tendler SJB, Williams PM. Observation of DNA-polymer condensate formation in real time at a molecular level. FEBS Lett. 2000; 480: 106-112.
40. Bielinska AU, KukowskaLatallo JF, Baker JR. The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA. Biochim. Biophys. Acta, Gene Struct. Expression 1997; 1353: 180-190.
41. Tang MX, Li WJ, Szoka FC. Toroid formation in charge neutralized flexible or semi-flexible biopolymers: potential pathway for assembly of DNA carriers. J. Gene. Med. 2005; 7: 334-342.
42. Takahashi T, Kono K, Itoh T, Emi N, Takagishi T. Synthesis of Novel Cationic Lipids Having Polyamidoamine Dendrons and Their Transfection Activity. Bioconjugate Chem. 2003; 14: 764-773.
43. Ogasawara S, Ikeda A, Kikuchi J. Positive Dendritic Effect in DNA/Porphyrin Composite Photocurrent Generators Containing Dendrimers as the Stationary Phase. Chem. Mater. 2006; 18: 5982-5987.
44. Waengler C, Moldenhauer G, Eisenhut M, Haberkorn U, Mier W. Antibody-dendrimer conjugates: The number, not the size of the dendrimers, determines the immunoreactivity. Bioconjugate Chem. 2008; 19: 813-820.
45. Plank C, Tang MX, Wolfe AR, Szoka FC. Branched cationic peptides for gene delivery: Role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes. Hum. Gene Ther. 1999; 10: 319-332.
46. Tziveleka LA, Psarra AMG, Tsiourvas D, Paleos CM. Synthesis and characterization of guanidinylated poly(propylene imine) dendrimers as gene transfection agents. J. Controlled Release 2007; 117: 137-146.
47. Okuda T, Sugiyama A, Niidome T, Aoyagi H. Characters of dendritic poly((L)-lysine) analogues with the terminal lysines replaced with arginines and histidines as gene carriers in vitro. Biomaterials 2004; 25: 537-544.
48. Albert A, Goldacre R, Phillips J. The strength of heterocyclic bases. J. Chem. Soc. 1948; 2240-2249.
49. Aissaoui A, Oudrhiri N, Petit L, Hauchecorne M, Kan E, Sainlos M, Julia S, Navarro J, Vigneron JP, Lehn JM, Lehn P. Progress in gene delivery by cationic lipids: Guanidinium-cholesterol-based systems as an example. Curr. Drug Targets 2002; 3: 1-16.
50. Lee I, Athey BD, Wetzel AW, Meixner W, Baker JR. Structural molecular dynamics studies on polyamidoamine dendrimers for a therapeutic application: Effects of pH and generation. Macromolecules 2002; 35: 4510-4520.
51. 6. J. Mol. Biol. 1980; 144: 431-453.
52. Manning GS. Molecular theory of polyelectrolyte solutions with applications to electrostatic properties of polynucleotides. Q. Rev. Biophys. 1978; 11: 179-246.
53. Wilson RW, Bloomfield VA. Counter-ion-induced condensation of deoxyribonucleic-acid-light-scattering study. Biochemistry 1979; 18: 2192-2196.